- Home
- INFU vs INO Comparison
INFU vs INO Comparison
Compare INFU & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- INO
- Stock Information
- Founded
- INFU 2005
- INO 1979
- Country
- INFU United States
- INO United States
- Employees
- INFU N/A
- INO N/A
- Industry
- INFU Medical/Dental Instruments
- INO Medical/Dental Instruments
- Sector
- INFU Health Care
- INO Health Care
- Exchange
- INFU Nasdaq
- INO Nasdaq
- Market Cap
- INFU 136.2M
- INO 110.7M
- IPO Year
- INFU N/A
- INO 1998
- Fundamental
- Price
- INFU $9.20
- INO $4.08
- Analyst Decision
- INFU
- INO Buy
- Analyst Count
- INFU 0
- INO 6
- Target Price
- INFU N/A
- INO $16.33
- AVG Volume (30 Days)
- INFU 94.3K
- INO 359.2K
- Earning Date
- INFU 11-07-2024
- INO 11-14-2024
- Dividend Yield
- INFU N/A
- INO N/A
- EPS Growth
- INFU 60.96
- INO N/A
- EPS
- INFU 0.07
- INO N/A
- Revenue
- INFU $132,783,999.00
- INO $203,413.00
- Revenue This Year
- INFU $10.49
- INO N/A
- Revenue Next Year
- INFU $8.84
- INO N/A
- P/E Ratio
- INFU $129.17
- INO N/A
- Revenue Growth
- INFU 8.17
- INO N/A
- 52 Week Low
- INFU $5.74
- INO $3.85
- 52 Week High
- INFU $10.99
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- INFU 68.15
- INO 19.02
- Support Level
- INFU $8.17
- INO $3.85
- Resistance Level
- INFU $9.30
- INO $5.60
- Average True Range (ATR)
- INFU 0.54
- INO 0.28
- MACD
- INFU 0.13
- INO -0.13
- Stochastic Oscillator
- INFU 75.47
- INO 6.67
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.